IRRAS

IRRAS is a public medical device company focused on developing and commercializing innovative systems for neurosurgical and neurocritical care. Its core achievement is the IRRAflow platform, an active, automated system designed to replace passive external ventricular drains, with the goal of reducing complications and improving the standard of care. The company's strategy involves direct sales in key European markets and distributor partnerships globally, supported by regulatory clearances including FDA 510(k). IRRAS seeks to establish its technology as a new standard in intracranial fluid management.

The IRRAflow platform is an active, automated system for intracranial fluid management, featuring a dual-lumen catheter for simultaneous irrigation/drainage and a computerized control unit to replace passive, gravity-based external ventricular drains.

IRRAS's main competition is the entrenched standard of passive EVDs from large medtech firms like Integra LifeSciences. Its true innovative competitors are few (e.g., Möller Medical's GAVIN system), giving IRRAS a first-mover advantage in active automation with its differentiated dual-lumen catheter technology.